Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa.

Camlin CS, Akullian A, Neilands TB, Getahun M, Bershteyn A, Ssali S, Geng E, Gandhi M, Cohen CR, Maeri I, Eyul P, Petersen ML, Havlir DV, Kamya MR, Bukusi EA, Charlebois ED.

Health Place. 2019 May;57:339-351. doi: 10.1016/j.healthplace.2019.05.002. Epub 2019 May 29.

2.

Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Drain PK, Dorward J, Bender A, Lillis L, Marinucci F, Sacks J, Bershteyn A, Boyle DS, Posner JD, Garrett N.

Clin Microbiol Rev. 2019 May 15;32(3). pii: e00097-18. doi: 10.1128/CMR.00097-18. Print 2019 Jun 19. Review.

PMID:
31092508
3.

Demographic and risk group heterogeneity across the UNAIDS 90-90-90 targets: a systematic review and meta-analysis protocol.

Green D, Kharono B, Tordoff DM, Akullian A, Bershteyn A, Morrison M, Garnett G, Duerr A, Drain P.

Syst Rev. 2019 May 6;8(1):110. doi: 10.1186/s13643-019-1024-6.

4.

The future of a partially effective HIV vaccine: assessing limitations at the population level.

Selinger C, Dimitrov DT, Welkhoff PA, Bershteyn A.

Int J Public Health. 2019 Apr 13. doi: 10.1007/s00038-019-01234-z. [Epub ahead of print]

PMID:
30982082
5.

Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.

Selinger C, Bershteyn A, Dimitrov DT, Adamson BJS, Revill P, Hallett TB, Phillips AN, Bekker LG, Rees H, Gray G.

Vaccine. 2019 Apr 10;37(16):2258-2267. doi: 10.1016/j.vaccine.2019.02.073. Epub 2019 Mar 16.

6.

The influence of mobility among high-risk populations on HIV transmission in Western Kenya.

Bershteyn A, Mutai KK, Akullian AN, Klein DJ, Jewell BL, Mwalili SM.

Infect Dis Model. 2018 Apr 23;3:97-106. doi: 10.1016/j.idm.2018.04.001. eCollection 2018.

7.

Implementation and applications of EMOD, an individual-based multi-disease modeling platform.

Bershteyn A, Gerardin J, Bridenbecker D, Lorton CW, Bloedow J, Baker RS, Chabot-Couture G, Chen Y, Fischle T, Frey K, Gauld JS, Hu H, Izzo AS, Klein DJ, McCarthy KA, Miller JC, Ouedraogo AL, Titova S, Wagner BG, Welkhoff PA, Wenger EA, Wiswell CN; Institute for Disease Modeling.

Pathog Dis. 2018 Jul 6. doi: 10.1093/femspd/fty059. [Epub ahead of print]

8.

Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.

Kirtane AR, Abouzid O, Minahan D, Bensel T, Hill AL, Selinger C, Bershteyn A, Craig M, Mo SS, Mazdiyasni H, Cleveland C, Rogner J, Lee YL, Booth L, Javid F, Wu SJ, Grant T, Bellinger AM, Nikolic B, Hayward A, Wood L, Eckhoff PA, Nowak MA, Langer R, Traverso G.

Nat Commun. 2018 Jan 9;9(1):2. doi: 10.1038/s41467-017-02294-6.

9.

The missing 27.

Akullian A, Bershteyn A, Jewell B, Camlin CS.

AIDS. 2017 Nov 13;31(17):2427-2429. doi: 10.1097/QAD.0000000000001638. No abstract available.

10.

Sexual partnership age pairings and risk of HIV acquisition in rural South Africa.

Akullian A, Bershteyn A, Klein D, Vandormael A, Bärnighausen T, Tanser F.

AIDS. 2017 Jul 31;31(12):1755-1764. doi: 10.1097/QAD.0000000000001553.

11.

Geographic coverage of male circumcision in western Kenya.

Akullian A, Onyango M, Klein D, Odhiambo J, Bershteyn A.

Medicine (Baltimore). 2017 Jan;96(2):e5885. doi: 10.1097/MD.0000000000005885.

12.
13.

Sustainable HIV treatment in Africa through viral-load-informed differentiated care.

Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa, Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P.

Nature. 2015 Dec 3;528(7580):S68-76. doi: 10.1038/nature16046.

14.

Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era.

Eaton JW, Bacaër N, Bershteyn A, Cambiano V, Cori A, Dorrington RE, Fraser C, Gopalappa C, Hontelez JA, Johnson LF, Klein DJ, Phillips AN, Pretorius C, Stover J, Rehle TM, Hallett TB.

Lancet Glob Health. 2015 Oct;3(10):e598-608. doi: 10.1016/S2214-109X(15)00080-7.

15.
16.

Association between economic growth and early childhood nutrition.

Bershteyn A, Lyons HM, Sivam D, Myhrvold NP.

Lancet Glob Health. 2015 Feb;3(2):e79-80. doi: 10.1016/S2214-109X(14)70382-1. No abstract available.

17.

The safety of public bicycle share programs in North America.

Salomon A, Kimbrough G, Bershteyn A.

Am J Public Health. 2014 Nov;104(11):e5-6. doi: 10.2105/AJPH.2014.302180. Epub 2014 Sep 11. No abstract available.

18.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2014 Jan;2(1):e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.

19.

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.

Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB.

Lancet Glob Health. 2013 Dec 10;2(1):23-34.

20.

Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.

Hanson MC, Bershteyn A, Crespo MP, Irvine DJ.

Biomacromolecules. 2014 Jul 14;15(7):2475-81. doi: 10.1021/bm500337r. Epub 2014 Jun 16.

21.

Dropout and re-enrollment: implications for epidemiological projections of treatment programs.

Klein DJ, Bershteyn A, Eckhoff PA.

AIDS. 2014 Jan;28 Suppl 1:S47-59. doi: 10.1097/QAD.0000000000000081.

PMID:
24468946
22.

Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.

Kim M, Song L, Moon J, Sun ZY, Bershteyn A, Hanson M, Cain D, Goka S, Kelsoe G, Wagner G, Irvine D, Reinherz EL.

J Biol Chem. 2013 Nov 1;288(44):31888-901. doi: 10.1074/jbc.M113.494609. Epub 2013 Sep 18.

23.

Age-dependent partnering and the HIV transmission chain: a microsimulation analysis.

Bershteyn A, Klein DJ, Eckhoff PA.

J R Soc Interface. 2013 Aug 28;10(88):20130613. doi: 10.1098/rsif.2013.0613. Print 2013 Nov 6.

24.

Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.

Tan S, Sasada T, Bershteyn A, Yang K, Ioji T, Zhang Z.

Nanomedicine (Lond). 2014 Apr;9(5):635-47. doi: 10.2217/nnm.13.67. Epub 2013 Aug 1.

PMID:
23905577
25.

A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns.

Bershteyn A, Eckhoff PA.

BMC Syst Biol. 2013 Feb 4;7:11. doi: 10.1186/1752-0509-7-11.

26.

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.

Eaton JW, Johnson LF, Salomon JA, Bärnighausen T, Bendavid E, Bershteyn A, Bloom DE, Cambiano V, Fraser C, Hontelez JA, Humair S, Klein DJ, Long EF, Phillips AN, Pretorius C, Stover J, Wenger EA, Williams BG, Hallett TB.

PLoS Med. 2012;9(7):e1001245. doi: 10.1371/journal.pmed.1001245. Epub 2012 Jul 10.

27.

Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.

Bershteyn A, Hanson MC, Crespo MP, Moon JJ, Li AV, Suh H, Irvine DJ.

J Control Release. 2012 Feb 10;157(3):354-65. doi: 10.1016/j.jconrel.2011.07.029. Epub 2011 Jul 24.

28.

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.

Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, Sohail M, Luo S, Um SH, Khant H, Goodwin JT, Ramos J, Chiu W, Irvine DJ.

Nat Mater. 2011 Mar;10(3):243-51. doi: 10.1038/nmat2960. Epub 2011 Feb 20.

29.

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.

Stephan MT, Moon JJ, Um SH, Bershteyn A, Irvine DJ.

Nat Med. 2010 Sep;16(9):1035-41. doi: 10.1038/nm.2198. Epub 2010 Aug 15.

30.

Block copolymer micelles as nanocontainers for controlled release of proteins from biocompatible oil phases.

Miller AC, Bershteyn A, Tan W, Hammond PT, Cohen RE, Irvine DJ.

Biomacromolecules. 2009 Apr 13;10(4):732-41. doi: 10.1021/bm800913r.

31.

Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells.

Tai K, Pelled G, Sheyn D, Bershteyn A, Han L, Kallai I, Zilberman Y, Ortiz C, Gazit D.

Tissue Eng Part A. 2008 Oct;14(10):1709-20. doi: 10.1089/ten.tea.2007.0241.

PMID:
18620480
32.

Polymer-supported lipid shells, onions, and flowers.

Bershteyn A, Chaparro J, Yau R, Kim M, Reinherz E, Ferreira-Moita L, Irvine DJ.

Soft Matter. 2008;4(9):1787-1791.

Supplemental Content

Loading ...
Support Center